With regard to pending marketing authorization applications, the register of the National Agency for Medicines (NAM) has so far disclosed only the filing date, the number of the applicants and applications and the active ingredient to a third party. In accordance with a recent decision from the Supreme Administrative Court, a third party is now also entitled to obtain, upon request, information on the identity of the applicant and the type of the application before the marketing authorization is granted.